Home/Filings/4/0001415889-25-002823
4//SEC Filing

Russell Steven Jon 4

Accession 0001415889-25-002823

CIK 0001674632other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 8:30 PM ET

Size

10.4 KB

Accession

0001415889-25-002823

Insider Transaction Report

Form 4
Period: 2025-01-31
Russell Steven Jon
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-01-31+53,58453,584 total
    Exercise: $5.10Exp: 2033-09-13Common Stock (53,584 underlying)
  • Award

    Employee Stock Option (right to buy)

    2025-01-31+90,63790,637 total
    Exercise: $17.00Exp: 2035-01-28Common Stock (90,637 underlying)
  • Award

    Employee Stock Option (right to buy)

    2025-01-31+81,21781,217 total
    Exercise: $7.51Exp: 2032-12-14Common Stock (81,217 underlying)
Footnotes (4)
  • [F1]One-fourth of the shares subject to this option shall vest one year after November 14, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.
  • [F2]Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.
  • [F3]The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
  • [F4]Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.

Issuer

Beta Bionics, Inc.

CIK 0001674632

Entity typeother

Related Parties

1
  • filerCIK 0002051384

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 8:30 PM ET
Size
10.4 KB